Beta-lactamase inhibitor

WikiDoc Resources for Beta-lactamase inhibitor
Articles
Most recent articles on Beta-lactamase inhibitor Most cited articles on Beta-lactamase inhibitor Review articles on Beta-lactamase inhibitor Articles on Beta-lactamase inhibitor in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Beta-lactamase inhibitor Images of Beta-lactamase inhibitor Photos of Beta-lactamase inhibitor Podcasts & MP3s on Beta-lactamase inhibitor Videos on Beta-lactamase inhibitor
Evidence Based Medicine
Cochrane Collaboration on Beta-lactamase inhibitor Bandolier on Beta-lactamase inhibitor TRIP on Beta-lactamase inhibitor
Clinical Trials
Ongoing Trials on Beta-lactamase inhibitor at Clinical Trials.gov Trial results on Beta-lactamase inhibitor Clinical Trials on Beta-lactamase inhibitor at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Beta-lactamase inhibitor NICE Guidance on Beta-lactamase inhibitor NHS PRODIGY Guidance FDA on Beta-lactamase inhibitor CDC on Beta-lactamase inhibitor
Books
Books on Beta-lactamase inhibitor
News
Beta-lactamase inhibitor in the news Be alerted to news on Beta-lactamase inhibitor News trends on Beta-lactamase inhibitor
Commentary
Blogs on Beta-lactamase inhibitor
Definitions
Definitions of Beta-lactamase inhibitor
Patient Resources / Community
Patient resources on Beta-lactamase inhibitor Discussion groups on Beta-lactamase inhibitor Patient Handouts on Beta-lactamase inhibitor Directions to Hospitals Treating Beta-lactamase inhibitor Risk calculators and risk factors for Beta-lactamase inhibitor
Healthcare Provider Resources
Symptoms of Beta-lactamase inhibitor Causes & Risk Factors for Beta-lactamase inhibitor Diagnostic studies for Beta-lactamase inhibitor Treatment of Beta-lactamase inhibitor
Continuing Medical Education (CME)
CME Programs on Beta-lactamase inhibitor
International
Beta-lactamase inhibitor en Espanol Beta-lactamase inhibitor en Francais
Business
Beta-lactamase inhibitor in the Marketplace Patents on Beta-lactamase inhibitor
Experimental / Informatics
List of terms related to Beta-lactamase inhibitor

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

File:Clavulanic acid structure.svg

Clavulanic acid

File:Sulbactam.svg

Sulbactam

File:Tazobactam structure.svg

Tazobactam

A beta-lactamase inhibitor is a drug given in conjunction with a beta-lactam antibiotic. Although the inhibitor does not usually have significant antibiotic activity on its own, it still plays an important role by disabling or slowing down the action of beta-lactamase.

Beta-lactamase inhibitors in clinical use include clavulanic acid and its potassium salt (usually combined with amoxicillin or ticarcillin), sulbactam and tazobactam.